Companies / BOC Sciences / Carlumab
BOC Sciences

Carlumab | BOC Sciences

Carlumab is a humanized anti-CCL2 (chemokine ligand 2) monoclonal antibody. Carlumab binds to CCL2 and inhibits angiogenesis and proliferation of tumor cells.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.